Hetero appoints Kshitiz Gadodia to Global Team as President - Finance & Accounts

Written By :  Ruchika Sharma
Published On 2025-11-18 09:49 GMT   |   Update On 2025-11-18 09:49 GMT
Advertisement

Hyderabad: Hetero has appointed Kshitiz Gadodia to its Global Team as President - Finance & Accounts.

With over 24 years of experience in finance and leadership, Kshitiz brings deep expertise and strategic insight to our global operations.

Before joining Hetero, he served as Chief Financial Officer at Intas Pharma. He also served various roles at Lupin, Novartis, Dr Reddy's Labs, Shell and Tolaram Group.

Advertisement

The Hetero Group is headquartered in Hyderabad, India. The company is one of world’s leading producers of key Active Pharmaceutical Ingredients (APIs) and generic formulations with presence in 140+ countries and backed by 30 years of experience in the pharma sector. 

Read also: Cipla, Hetero win bid to supply widely prescribed diabetes drug in China



Tags:    

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News